An open-label, randomized, placebo-controlled study on the effectiveness of a novel probiotics administration protocol (ProbiotiCKD) in patients with mild renal insufficiency (stage 3a of CKD)

An open-label, randomized, placebo-controlled study on the effectiveness of a novel probiotics administration protocol (ProbiotiCKD) in patients with mild renal insufficiency (stage 3a of CKD). https://t.co/Su3nVtTZc1

An open-label, randomized, placebo-controlled study on the effectiveness of a novel probiotics administration protocol (ProbiotiCKD) in patients with mild renal insufficiency (stage 3a of CKD). https://t.co/jhitpPns7l

An open-label, randomized, placebo-controlled study on the effectiveness of a novel probiotics administration protocol (ProbiotiCKD) in patients with mild renal insufficiency (stage 3a of CKD). https://t.co/QNUwO5yuIJ https://t.co/5ilemc8C4R

An open-label, randomized, placebo-controlled study on the effectiveness of a novel probiotics administration protocol (ProbiotiCKD) in patients with mild renal insufficiency (stage 3a of CKD). https://t.co/JxAOlxslSc https://t.co/dqyQNtwJlE

[PubMed] An open-label, randomized, placebo-controlled study on the effectiveness of a novel probiotics administration protocol (ProbiotiCKD) in patients with mild renal insufficiency (stage 3a of CKD). https://t.co/hRR5HjkXmv

An open-label, randomized, placebo-controlled study on the effectiveness of ... - Simeoni M et al. - https://t.co/ptlzkTgOgI #microbiome

RT @HealthyFellow: #Probiotic #Supplement May Reduce #Dysbiosis, #Inflammation in #Patients with Early-Stage #Kidney #Disease via @Springer…

#Probiotic #Supplement May Reduce #Dysbiosis, #Inflammation in #Patients with Early-Stage #Kidney #Disease via @SpringerOpen https://t.co/tdqJJhcXqG Attn: @nkf @ASNKidney @IpcProbiotic #gut #health #medicine #microbiome